Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
MTDRMatador Resources CoNov 5 – Nov 56 insiders$507K
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 21 | Mat IshbiaDirector, President and CEO, 10% Owner |  UWMCUWM Holdings CorpOpen-market sale · 10b5-1 plan | SELL | $3.91M 1.00M sh | Apr 13, 2026 |
| 21 | Mat IshbiaDirector, President and CEO, 10% Owner | UWMCUWM Holdings Corp Open-market sale · 10b5-1 plan | SELL | $3.71M 1.00M sh | Apr 13, 2026 traded Apr 10, 2026 |
| 21 | Mat IshbiaDirector, President and CEO, 10% Owner | UWMCUWM Holdings Corp Open-market sale · 10b5-1 plan | SELL | $3.66M 1.00M sh | Apr 13, 2026 traded Apr 13, 2026 |
| 19 | Pomel OlivierDirector, Chief Executive Officer |  DDOGDatadog, Inc.Open-market sale · 10b5-1 plan | SELL | $1.61M 14.7K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 19 | Erlinger Joseph M.President, McDonald's USA |  MCDMCDONALDS CORPOpen-market sale · 10b5-1 plan | SELL | $806K 2,626 sh | Apr 13, 2026 traded Apr 10, 2026 |
| 19 | Kao John EDirector, Chief Executive Officer |  ALHCAlignment Healthcare, Inc.Open-market sale · 10b5-1 plan | SELL | $4.16M 201.9K sh | Apr 13, 2026 traded Apr 10, 2026 |
| 17 | Cornelissen Bart JanSR. VICE PRESIDENT & CFO |  XNCRXencor IncOpen-market sale | SELL | $43K 3,499 sh | Apr 13, 2026 traded Apr 10, 2026 |
| 16 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $204K 15.7K sh | Apr 13, 2026 traded Apr 13, 2026 |
| 16 | Pomel OlivierDirector, Chief Executive Officer | DDOGDatadog, Inc. Open-market sale · 10b5-1 plan | SELL | $464K 4,100 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 16 | Pelish Henry E.Chief Scientific Officer |  NUVLNuvalent, Inc.Open-market sale · 10b5-1 plan | SELL | $95K 900 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 16 | Pomel OlivierDirector, Chief Executive Officer | DDOGDatadog, Inc. Open-market sale · 10b5-1 plan | SELL | $627K 5,700 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 16 | Pelish Henry E.Chief Scientific Officer | NUVLNuvalent, Inc. Open-market sale · 10b5-1 plan | SELL | $229K 2,193 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 16 | Howard Justyn RussellDirector, Executive Chair, 10% Owner |  SPTSprout Social, Inc.Open-market sale · 10b5-1 plan | SELL | $201K 40.0K sh | Apr 13, 2026 traded Apr 10, 2026 |
| 16 | Pomel OlivierDirector, Chief Executive Officer | DDOGDatadog, Inc. Open-market sale · 10b5-1 plan | SELL | $307K 2,699 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 16 | Pomel OlivierDirector, Chief Executive Officer | DDOGDatadog, Inc. Open-market sale · 10b5-1 plan | SELL | $515K 4,606 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 16 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $238K 18.7K sh | Apr 13, 2026 traded Apr 10, 2026 |
| 16 | Pomel OlivierDirector, Chief Executive Officer | DDOGDatadog, Inc. Open-market sale · 10b5-1 plan | SELL | $810K 7,295 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 16 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $234K 17.0K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 13 | Pomel OlivierDirector, Chief Executive Officer | DDOGDatadog, Inc. Open-market sale · 10b5-1 plan | SELL | $129K 1,100 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 13 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $5,392 400 sh | Apr 13, 2026 traded Apr 10, 2026 |
| 13 | Pomel OlivierDirector, Chief Executive Officer | DDOGDatadog, Inc. Open-market sale · 10b5-1 plan | SELL | $83K 700 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 13 | Pomel OlivierDirector, Chief Executive Officer | DDOGDatadog, Inc. Open-market sale · 10b5-1 plan | SELL | $58K 500 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 13 | Pomel OlivierDirector, Chief Executive Officer | DDOGDatadog, Inc. Open-market sale · 10b5-1 plan | SELL | $116K 1,000 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 13 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $30K 2,100 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 13 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $47K 3,338 sh | Apr 13, 2026 traded Apr 13, 2026 |
| 12 | Kao John EDirector, Chief Executive Officer | ALHCAlignment Healthcare, Inc. Open-market sale · 10b5-1 plan | SELL | $295K 13.8K sh | Apr 13, 2026 traded Apr 10, 2026 |
| 12 | Kao John EDirector, Chief Executive Officer | ALHCAlignment Healthcare, Inc. Open-market sale · 10b5-1 plan | SELL | $1.71M 82.3K sh | Apr 13, 2026 traded Apr 13, 2026 |
| 11 | Perducat CyrilSVP, Chief Technology Officer | ROKROCKWELL AUTOMATION, INC Open-market sale · 10b5-1 plan | SELL | $78K 198 sh | Apr 13, 2026 traded Apr 10, 2026 |
| 11 | Azar Samak LChief Legal Officer |  GFSGLOBALFOUNDRIES Inc.Open-market sale · 10b5-1 plan | SELL | $24K 500 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 11 | Nagendran SukumarDirector, President and Head of R&D |  TSHATaysha Gene Therapies, Inc.Open-market sale · 10b5-1 plan | SELL | $892K 200.0K sh | Apr 13, 2026 traded Apr 10, 2026 |
| 10 | Das SouvikChief Technology Officer |  CWANClearwater Analytics Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $240K 10.0K sh | Apr 13, 2026 traded Apr 8, 2026 |
| 8 | Moat RossCHIEF OPERATING OFFICER |  KNSAKiniksa Pharmaceuticals International, plcOpen-market sale · 10b5-1 plan | SELL | $80K 1,703 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 8 | O'Connor CaseyChief Legal Officer |  SFIXStitch Fix, Inc.Open-market sale · 10b5-1 plan | SELL | $185K 60.0K sh | Apr 13, 2026 traded Apr 10, 2026 |
| 6 | Rodman David MalcomChief Medical Officer |  MLYSMineralys Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $59K 2,170 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 5 | Freemen-Bosworth LaurenEVP/Gen Counsel & Corp Sec |  PBIPITNEY BOWES INC /DE/Open-market sale · 10b5-1 plan | SELL | $7,970 693 sh | Apr 13, 2026 traded Apr 10, 2026 |
| 1 | Cook MeredithSR. VP, GENERAL COUNSEL & SEC. |  ANIPANI PHARMACEUTICALS INCOpen-market sale · 10b5-1 plan | SELL | $39K 500 sh | Apr 13, 2026 traded Apr 13, 2026 |
| 1 | Rosenbaum Michael GeorgeDirector, Chief Executive Officer |  GWREGuidewire Software, Inc.Open-market sale · 10b5-1 plan | SELL | $143K 1,200 sh | Apr 13, 2026 traded Apr 13, 2026 |
| 51 | Velaga S. RamPresident, ISG |  AVGOBroadcom Inc.Open-market sale | SELL | $6.08M 17.3K sh | Apr 10, 2026 traded Apr 9, 2026 |
| 51 | Page JustineDirector | AVGOBroadcom Inc. Open-market sale | SELL | $712K 2,018 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 50 | Kawwas Charlie BPresident, SSG | AVGOBroadcom Inc. Open-market sale | SELL | $3.45M 10.0K sh | Apr 10, 2026 traded Apr 8, 2026 |